Thursday, 26 May, 2016 | Alice Moorey, Catia Gaspar, Steve Caiger, Alexandre Akoulitchev, Antoine Verslype
In the last 20 years there has been much research and knowledge gained about the ageing process, epigenetics and the role of nutrition along the life course. Sibelius strategy helps to bring these three fundamental quests together. With those insights the Company is building new pipelines of bioactive natural products for various aspects of health and age related conditions. With C. elegans as a model organism and the automated Chronoscreen™ platform for evaluation of biological activities, modes of action and efficacies, the Company has been able to engage in proprietary development and re-formulation of new products of high efficacy.
Read the full article here.